Summit Therapeutics Reports Financial Results for the Second Quarter Ended 31 July 2015 and Operational Progress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. FDX
3. META
4. ABBV
5. SPY
6. IBM
7. NKE
8. MU
9. USO
10. NVDA

Go back to Summit Therapeutics Reports Financial Results for the Second Quarter Ended 31 July 2015 and Operational Progress

Summit Therapeutics (SMMT) Reports Q2 Loss of GBP0.07/Share

August 27, 2015 7:28 AM EDT

Summit Therapeutics (NASDAQ: SMMT) reported Q2 EPS of (GBP0.07), versus (GBP0.08) reported last year.

For earnings history and earnings-related data on Summit Therapeutics (SMMT) click here.

... More